Zolpidem tartrate and Photopsia - a phase IV clinical study of FDA data
Photopsia is found among people who take Zolpidem tartrate, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Zolpidem tartrate and have Photopsia. It is created by eHealthMe based on reports of 27,192 people who have side effects when taking Zolpidem tartrate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
27,192 people reported to have side effects when taking Zolpidem tartrate.
Among them, 6 people (0.02%) have Photopsia.
What is Zolpidem tartrate?
Zolpidem tartrate has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 28,219 Zolpidem tartrate users for its effectiveness, alternative drugs and more.
What is Photopsia?
Photopsia (presence of perceived flashes of light) is found to be associated with 1,256 drugs and 779 conditions by eHealthMe.
Number of Zolpidem tartrate and Photopsia reports submitted per year:
Time on Zolpidem tartrate when people have Photopsia *:
- < 1 month: 50 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 50 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Photopsia when taking Zolpidem tartrate *:
- female: 50 %
- male: 50 %
Age of people who have Photopsia when taking Zolpidem tartrate *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 33.33 %
- 50-59: 33.33 %
- 60+: 33.33 %
Common drugs people take besides Zolpidem tartrate *:
- Xanax: 1 person, 16.67%
- Valproate Sodium: 1 person, 16.67%
- Valium: 1 person, 16.67%
- Risperidone: 1 person, 16.67%
- Rebetol: 1 person, 16.67%
- Premarin: 1 person, 16.67%
- Oxycontin: 1 person, 16.67%
- Mirtazapine: 1 person, 16.67%
- Mellaril: 1 person, 16.67%
- Lithium Carbonate: 1 person, 16.67%
Common side effects people have besides Photopsia *:
- Visual Acuity Reduced (reduced clearness of vision): 2 people, 33.33%
- Eye Pain: 2 people, 33.33%
- Dizziness: 2 people, 33.33%
- Vitreous Floaters (spots before the eyes): 1 person, 16.67%
- Dry Skin: 1 person, 16.67%
- Growth Of Eyelashes: 1 person, 16.67%
- Glare (difficulty seeing in the presence of bright light): 1 person, 16.67%
- Gingival Bleeding (bleeding gums): 1 person, 16.67%
- Feeling Hot: 1 person, 16.67%
- Fear: 1 person, 16.67%
Common conditions people have *:
- Memory Loss: 1 person, 16.67%
- High Blood Pressure: 1 person, 16.67%
- Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 16.67%
- Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 16.67%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 16.67%
- Depression: 1 person, 16.67%
- Acne (skin problems that cause pimples): 1 person, 16.67%
* Approximation only. Some reports may have incomplete information.
Do you take Zolpidem tartrate and have Photopsia?Check whether Photopsia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
- Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
- Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
How severe was Photopsia and when was it recovered:
Expand to all the drugs that have ingredients of zolpidem tartrate:
Alternative drugs to, pros and cons of Zolpidem tartrate:
- Zolpidem tartrate (28,219 reports)
Common Zolpidem tartrate side effects:
Browse all side effects of Zolpidem tartrate:a b c d e f g h i j k l m n o p q r s t u v w x y z
Photopsia treatments and more:
- Photopsia (7,041 reports)
COVID vaccines that are related to Photopsia:
- Photopsia in Moderna COVID Vaccine
- Photopsia in Pfizer BioNTech Covid Vaccine
- Photopsia in Johnson and Johnson Covid Vaccine
Common drugs associated with Photopsia:
All the drugs that are associated with Photopsia:
- Photopsia (1,256 drugs)
Common conditions associated with Photopsia:
All the conditions that are associated with Photopsia:
- Photopsia (779 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on zolpidem tartrate (the active ingredients of Zolpidem tartrate) and Zolpidem tartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Flexeril and Small Intestinal Obstruction - 10 seconds ago
- Lo/Ovral and Premarin drug interaction - 11 seconds ago
- Symlin and Clonazepam drug interaction - 18 seconds ago
- Biaxin and Omniscan drug interaction - 29 seconds ago
- Neoral and Serratia Infection - 30 seconds ago
- Zafirlukast and Gilenya drug interaction - 49 seconds ago
- Alphagan and Appetite - Decreased - a minute ago
- Alphagan and Appetite Decreased - a minute ago
- Finasteride and Tagamet drug interaction - a minute ago
- Omnaris and Proair Hfa drug interaction - a minute ago